Oppenheimer & Co. Inc.

Getting older is inevitable – but what if feeling old wasn’t? In the latest episode of Let’s Talk Future, Jane Ross sits down with Jay Olson, Managing Director and Senior Analyst at Oppenheimer, to explore the fast-growing world of longevity science—where healthcare innovation is focused not just on extending lifespan, but improving healthspan. They dive into the science of aging, the breakthroughs reshaping preventative medicine, and the companies at the forefront of this movement—Amgen, Biogen, Viking, Denali, Merck, GSK, L’Oréal, and BioAge Labs—all pushing boundaries in biotech and wellness. Whether you're curious about biotech, investing in innovation, or the future of healthcare, this conversation highlights why longevity is emerging as one of the most important themes of the next decade. #ThePowerofOppenheimerThinking

Robots aren’t just coming — they’re already here. Across mining, logistics, defense, trucking, and even personal transportation, physical AI is moving from hype to real-world adoption. These self-learning robots are making the movement of goods, materials, and people faster, safer, and more efficient — and in the process, they’re starting to reshape entire industries. But what does this mean for the future of work, investment, and innovation? In the latest episode of Let’s Talk Future, host Jane Ross sits down with Colin Rusch, Managing Director and Head of Oppenheimer’s Sustainable Growth & Resource Optimization franchise, to explore how physical AI could spark the next industrial revolution. #ThePowerofOppenheimerThinking

2025 was supposed to be the year of the deal—IPOs, M&A, and market momentum. The reality? A mixed bag, with some headline-making wins and plenty of uncertainty. In this episode of Let’s Talk Future, Jane Ross sits down with John Hyland, Managing Director in Equity Capital Markets at Oppenheimer, to unpack: • What’s really happening in today’s deal landscape • The sectors drawing the most investor interest • Risks that could shape the second half of the year • Why IPOs still play a critical role in market growth #ThePowerofOppenheimerThinking

Oppenheimer was built on strength, trust, and partnership. Advisors who join us don’t just find a team—they find the edge that takes them further.

Oppenheimer Asset Management helps financial professionals grow through trust, innovation, and a platform built for lasting success.